The role of infection and chronic inflammation in plasma cell disorders (PCD) has been well-
described. Despite not being a diagnostic criterion, infection is a common complication of …

Chronic lymphocytic leukaemia (CLL) is the most common leukaemia with infections a
leading cause of morbidity and mortality. Recently there has been a paradigm shift from the …

Background The objective of this review was to determine the impact of immunomodulatory
drugs (IMiDs) and proteasome inhibitor (PI)–based therapy on infection risk in patients with …

The treatment of multiple myeloma is considered a continuously evolving paradigm as a
result of the growing availability of new and highly effective drugs, including first-and second …

Background Infection is a leading cause of morbidity and death in patients with multiple
myeloma (MM). The increased susceptibility to infection is complicated and multifactorial …

Infectious diseases are the leading causes of death in patients with multiple myeloma (MM).
Major changes have occurred in the spectrum of infections paralleling the changes in the …

Introduction Despite many recent advances in the treatment of multiple myeloma (MM),
infection remains a major cause of morbidity and mortality. Prior studies have shown mixed …

Viral infections of the respiratory system represent one of the most important complications
in hematological patients in terms of both the severity of the clinical picture and its related …

Infection remains a significant contributor to morbidity and mortality in patients with
myeloma. This guideline was developed by a multidisciplinary group of clinicians who …

Background Viral reactivations are frequent in hematologial patients due to their cancer‐
related and drug‐induced immunosuppressive status. Daratumumab, an anti‐CD38 …